CDK9 and acute myeloid leukemia: BTX-A51 also demonstrated a “rapid-hit” mechanism with near-complete elimination of CDK7/CDK9 mediated RNA Pol II phosphorylation and Mdm2 expression after only 5 minutes of treatment in a mouse AML cells (20).